We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Authorizes Second COVID-19 Booster Shots for Older Adults, Immunocompromised Patients
FDA Authorizes Second COVID-19 Booster Shots for Older Adults, Immunocompromised Patients
The FDA has authorized second booster doses of the Pfizer and Moderna COVID-19 vaccines for adults aged 50 years and older and younger immunocompromised individuals.